Ex-hedge funder buys rights to AIDS drug and raises price from $13.50 to $750 per pill
▻http://www.rawstory.com/2015/09/ex-hedge-funder-buys-rights-aids-drug-and-raises-price-from-13-50-to-750-p
-
-
-
Apparemment, c’est une pratique en vogue dans le secteur.
Voir cette article qui parle aussi du #Daraprim et d’autres molécules soumises à augmentation spéculative. ▻http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?_r=0
Turing’s price increase is not an isolated example. Although most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer, hepatitis C and high cholesterol, there is also growing concern about huge price increases on older drugs, some of them generic, that have long been mainstays of treatment.
Although some price increases have been caused by shortages, others have resulted from a business strategy of buying old neglected drugs and turning them into high-priced “specialty drugs.” -
Martin Shkreli, le #prédateur des maladies orphelines est sous le coup d’une enquête concernant son passage chez Retrophin (▻http://www.bloomberg.com/bw/articles/2014-04-17/retrophins-martin-shkreli-the-biotech-short-seller-who-went-long) de la part de ses anciens collaborateurs(▻http://www.sec.gov/Archives/edgar/data/1438533/000119312515292581/d19898dex991.htm).
A Biotech Company Escalates the War Against Its Own Founder
▻http://www.bloomberg.com/news/articles/2015-08-17/a-biotech-company-escalates-the-war-against-its-own-founder
#biotech_is_godzilla -
-
-
En France,
▻https://www.vidal.fr/Medicament/malocide_50_mg_cp-10501-prescription_delivrance_prise_en_charge.htmPrix : 12,94 euros (20 comprimés).
-
Celui-ci est particulièrement gratiné mais c’est un peu l’arbre qui cache la forêt : comme dit @supergeante, c’est très courant dans tout le secteur, où l’on met le profit avant la vie, avec des conséquences tragiques pour des millions de personnes. L’indignation morale doit devenir politique.
-
-
